摘要
成纤维细胞生长因子21(FGF21)是成纤维细胞生长因子家族的一员,具有降脂、抗炎、抗氧化等生物学作用。近年来研究发现,FGF21能够有效抑制血管钙化,降低心血管事件的发生,被视为心血管系统新的保护因素,有望成为临床上防治血管钙化的新靶点。本文就FGF21与血管钙化关系的最新研究进展做一综述。
Fibroblast growth factor 21(FGF21)is a member of the fibroblast growth factor family,which has biological effects such as lipid-lowering,anti-inflammation and anti-oxidation.In recent years,studies have found that FGF21 can effectively inhibit vascular calcification and reduce the occurrence of cardiovascular events.So,it has been regarded as a new protective factor for the cardiovascular system,and is expected to become a new clinical target for the prevention and treatment of vascular calcification.This article reviewed the latest research progress on the relationship between FGF21 and vascular calcification.
作者
夏庆玲
欧三桃
Qingling Xia;Santao Ou(Department of Nephrology,Affiliated Hospital of Southwest Medical University,Sichuan Clinical Research Center for Nephrology,Luzhou 646000,Sichuan Province,China)
出处
《中华肾病研究电子杂志》
2022年第4期231-234,共4页
Chinese Journal of Kidney Disease Investigation(Electronic Edition)
基金
四川省肾脏疾病临床医学研究中心2020年开放课题重点项目(2019YFS0537-3)